Release Date: 07/01/15 18:09 Summary: Amendments to CEO Remuneration & Incentive Arrangements Price Sensitive: No Download Document 1.98MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%